Judy Garber on PARP Inhibitors for Triple-Negative Breast Cancer
November 15, 2017
In this Q&A we discuss the role of PARP inhibitors in cancer treatment, their role in triple-negative breast cancer patients and look forward to ongoing trials in this setting.
